Corporate ProfileWe are a clinical stage biotechnology company developing first-in-class antibody product candidates focused on unmet medical needs in inflammation.
Data provided by Nasdaq. Minimum 15 minutes delayed.
Mar 04, 2017AnaptysBio Announces Data from Scientific Collaboration with the Benaroya Research Institute Presented at the AAAAI 2017 Annual Meeting
There are currently no events scheduled.